ID: ALA1203585

Max Phase: Preclinical

Molecular Formula: C19H24ClF2N3O4

Molecular Weight: 377.39

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cl.O.O=C(O)c1cn(CCF)c2cc(N3CCN4CCC3CC4)c(F)cc2c1=O

Standard InChI:  InChI=1S/C19H21F2N3O3.ClH.H2O/c20-3-6-23-11-14(19(26)27)18(25)13-9-15(21)17(10-16(13)23)24-8-7-22-4-1-12(24)2-5-22;;/h9-12H,1-8H2,(H,26,27);1H;1H2

Standard InChI Key:  DGIVZRNPTBKGER-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 377.39

Molecular Weight (Monoisotopic): 377.1551

AlogP: 2.09

#Rotatable Bonds: 4

Polar Surface Area: 65.78

Molecular Species: ACID

HBA: 5

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 5.62

CX Basic pKa: 7.27

CX LogP: -0.08

CX LogD: -0.28

Aromatic Rings: 2

Heavy Atoms: 27

QED Weighted: 0.88

Np Likeness Score: -0.83

References

1. McGuirk PR, Jefson MR, Mann DD, Elliott NC, Chang P, Cisek EP, Cornell CP, Gootz TD, Haskell SL, Hindahl MS..  (1992)  Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine.,  35  (4): [PMID:1311762] [10.1021/jm00082a001]

Source

Source(1):

• Scientific Literature